FibroGen, Inc. (FGEN) was a big mover last session with its shares rising almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally reverses the recent downtrend for the company, as the stock is now down over 23% in the past one-month time frame.
Over the last 30 days, this company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
FibroGen currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Another favorably-ranked stock in the med-drugs industry is Valeant Pharmaceuticals International, Inc. (VRX) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment